MSB 4.59% $1.14 mesoblast limited

2024 Here we go again., page-570

  1. 590 Posts.
    lightbulb Created with Sketch. 298
    don't think there is a possibility of 2 month review?

    there wasn't any mention of their previously discussed intention to plan a meeting regarding hlhs. must be too much on their plate or a lower prioirity indication from a strategic perspective. i guess that can be an add on to other chf discussions.

    eap in adults was up to 51 patients but included adolescents. i wonder what percentage of that 51 is between the age of 12 and 18 and if that might have any implications in terms of the adequacy of evidence to extend into adult ages . if that's the case and it poses an issue to the extension strategy, i guess it wont take too long gather more evidence
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.14
Change
0.050(4.59%)
Mkt cap ! $1.301B
Open High Low Value Volume
$1.10 $1.14 $1.08 $6.654M 5.972M

Buyers (Bids)

No. Vol. Price($)
2 1330 $1.14
 

Sellers (Offers)

Price($) Vol. No.
$1.14 171164 10
View Market Depth
Last trade - 16.10pm 18/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.